Buy Full Version
"Europe Transdermal Skin Patches Market"

Let us help you !

Invalid Email.

Please Select Country.

Invalid contact no.

Special Symbols Not Allowed.

Invalid Security Code.

Thank You For Your Interest.

We've Successfully Got Your Message,

Our Executive will get back to you Shortly.

Europe Transdermal Skin Patches Market by Indication (Hormonal Disorders, Cardiac Disorders, Migraine, Parkinsons Disease, Alzheimers, HIV, Osteoporosis, and Dermatological Diseases) - Opportunities and Forecasts, 2019-2026

Medical Devices & Supplies	LI_183515	Pages: NA	Jan 2020 \| 1228 Views
Author(s) : NA	Tables: NA	Charts: NA	Formats*:

Transdermal patch is a type of transdermal technology. It is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication. These patches deliver a medication dose through the skin using a diffusion technique, which is later released in the blood stream over a long period of time.

The European transdermal skin patches market is expected to witness significant growth during the forecast period due to factors such as increasing advantages over oral & ingesting medications, ease of administration, and prolonged activity of the drug. Although these factors boost the growth of the market, factors such as non-permeability of the skin among patients to absorb a range of medications coupled with the development of contact dermatitis at the site of application of transdermal patches can limit the market growth.

The European transdermal skin patches market has been segmented on the basis of indication and countries. By indication, the market is segmented into hormonal disorders, cardiac disorders, migraine, Parkinson’s disease, Alzheimer’s, HIV, osteoporosis, dermatological diseases, and others. Geographically, the market has been analyzed across Germany, France, UK, Italy, Spain, and rest of Europe.

The major players in the transdermal patches market include Teva Pharmaceutical Industries Ltd., Mylan Pharmaceuticals Inc, 3M Company, Accrux Ltd., and Access Pharmaceuticals Inc.

Key Benefits

The study provides an in-depth analysis of the market along with current trends and future estimations to elucidate imminent investment pockets.
Extensive analysis of the market has been conducted by following key product positioning and monitoring the top competitors within the market framework.
It offers a quantitative analysis from 2016 to 2023 to enable stakeholders to capitalize on prevailing market opportunities.
Key players have been profiled and their strategies thoroughly analyzed to understand the competitive outlook of the European market.
Comprehensive analysis of all countries in Europe has been provided that determines prevailing opportunities globally.

Europe Transdermal Skin Patches Market Key Segments:

By Indication

Hormonal Disorders
Cardiac Disorders
Migraine
Parkinson’s Disease
Alzheimer’s
HIV
Osteoporosis
Dermatological Diseases
Others

By Country

Germany
France
UK
Italy
Spain
Rest of Europe

CHAPTER 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

CHAPTER 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. MARKET SHARE ANALYSIS, 2016
3.4. PORTER’S FIVE FORCES ANALYSIS

3.4.1. MARKET DYNAMICS
3.4.2. Drivers
3.4.3. Restraints
3.4.4. Opportunities

CHAPTER 4 EUROPE TRANSDERMAL SKIN PATCHES MARKET, BY INDICATION

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. HORMONAL DISORDERS

4.2.1. Key market trends
4.2.2. Key growth factors and opportunities
4.2.3. Market size and forecast

4.3. CARDIAC DISORDERS

4.3.1. Key market trends
4.3.2. Key growth factors and opportunities
4.3.3. Market size and forecast

4.4. MIGRAINE

4.4.1. Key market trends
4.4.2. Key growth factors and opportunities
4.4.3. Market size and forecast

4.5. PARKINSON’S DISEASE

4.5.1. Key market trends
4.5.2. Key growth factors and opportunities
4.5.3. Market size and forecast

4.6. ALZHEIMER’S

4.6.1. Key market trends
4.6.2. Key growth factors and opportunities
4.6.3. Market size and forecast

4.7. HIV

4.7.1. Key market trends
4.7.2. Key growth factors and opportunities
4.7.3. Market size and forecast

4.8. OSTEOPOROSIS

4.8.1. Key market trends
4.8.2. Key growth factors and opportunities
4.8.3. Market size and forecast

4.9. DERMATOLOGICAL DISEASES

4.9.1. Key market trends
4.9.2. Key growth factors and opportunities
4.9.3. Market size and forecast

4.10. OTHERS

4.10.1. Key market trends
4.10.2. Key growth factors and opportunities
4.10.3. Market size and forecast

CHAPTER 5 EUROPE TRANSDERMAL SKIN PATCHES MARKET, BY COUNTRY

5.1. OVERVIEW
5.2. KEY MARKET TRENDS
5.3. KEY GROWTH FACTORS AND OPPORTUNITIES
5.4. MARKET SIZE AND FORECAST

5.4.1. Germany market size and forecast
5.4.2. France market size and forecast
5.4.3. UK market size and forecast
5.4.4. Italy market size and forecast
5.4.5. Spain market size and forecast
5.4.6. Rest of Europe market size and forecast

CHAPTER 6 COMPANY PROFILES

6.1. TEVA PHARMACEUTICAL INDUSTRIES LTD.

6.1.1. Operating business segments
6.1.2. Business performance
6.1.3. Key strategic moves and developments

6.2. MYLAN PHARMACEUTICALS INC.

6.2.1. Operating business segments
6.2.2. Business performance
6.2.3. Key strategic moves and developments

6.3. 3M COMPANY

6.3.1. Operating business segments
6.3.2. Business performance
6.3.3. Key strategic moves and developments

6.4. ACCRUX LTD.

6.4.1. Operating business segments
6.4.2. Business performance
6.4.3. Key strategic moves and developments

6.5. ACCESS PHARMACEUTICALS INC.

6.5.1. Operating business segments
6.5.2. Business performance
6.5.3. Key strategic moves and developments

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
Technologically sophisticated and reliable insights through well audited and veracious research methodology
Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

Patent and regulatory databases for understanding of technical & legal developments
Scientific and technical writings for product information and related preemptions
Regional government and statistical databases for macro analysis
Authentic new articles, web-casts and other related releases for market evaluation
Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

Validates and improves the data quality and strengthens research proceeds
Further develops analyst team’s market understanding and expertise
Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

Chief executives and VPs of leading corporations specific to industry
Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

Online Only ~~$3,456~~ $3,041 Data Pack/Excel ~~$3,840~~ $3,379 Single User License ~~$5,370~~ $4,726 Five User License ~~$6,450~~ $5,676 Enterprise User License ~~$8,995~~ $7,916

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,
Int'l : +1-503-894-6022
( Europe )
+ 44-845-528-1300
Drop us an email at
help@alliedmarketresearch.com